Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reconsolidation therapy with propranolol for post-traumatic stress disorder
2022-500870-32-02Phase 2Authorised
- Sponsor
- Erasmus Hospital
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by Erasmus Hospital. Primary endpoint: PCL-S: Posttraumatic Stress Disorder Checklist Scale. Planned start Feb 2023; status: authorised.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2022-500870-32-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500870-32-02.